Elsabagh S, Hartley DE, File SE. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba. J.Psychopharmacol. 2005;19(2):173-181.

Engelsen J, Nielsen JD, Hansen KF. [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr.Laeger 4-28-2003;165(18):1868-1871.

He M, Zhang XM, Yuan HQ. [Clinical study on treatment of pulmonary interstitial fibrosis with ginkgo extract]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2005;25(3):222-224.

Hilton M, Stuart E. Ginkgo biloba for tinnitus. Cochrane.Database.Syst.Rev. 2004;(2):CD003852.

Horsch S, Walther C. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies. Int.J.Clin.Pharmacol.Ther. 2004;42(2):63-72.

Issing W, Klein P, Weiser M. The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial. J.Altern.Complement Med. 2005;11(1):155-160.

Kampman K, Majewska MD, Tourian K, et al. A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence. Addict.Behav 2003;28(3):437-448.

Kohler S, Funk P, Kieser M. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coagul.Fibrinolysis 2004;15(4):303-309.

Mazza M, Capuano A, Bria P, et al. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Eur J Neurol. 2006 Sep;13(9):981-5.

Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000;108(4):276-281.

Raabe A, Raabe M, Ihm P. [Therapeutic follow-up using automatic perimetry in chronic cerebroretinal ischemia in elderly patients. Prospective double-blind study with graduated dose ginkgo biloba treatment (EGb 761)]. Klin Monatsbl Augenheilkd 1991;199(6):432-438.

Sikora R, Sohn MH, Engelke B, et al. Randomized placebo-controlled study on the effects of oral treatment with Gingko biloba extract in patients with erectile dysfunction. J Urology 1998;159(suppl 5):240.

Van Dongen M, van Rossum E, Kessels A, et al. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol. 2003;56(4):367-376.

Wheatley D. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum.Psychopharmacol. 2004;19(8):545-548.

Wolf HR. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily? Drugs R D. 2006;7(3):163-72.


Adams LL, Gatchel RJ, Gentry C. Complementary and alternative medicine: applications and implications for cognitive functioning in elderly populations. Altern Ther Health Med . 2001;7(2):52-61.

Aruna D, Naidu MU.Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects. Br J Clin Pharmacol . 2006 Sep 29; [Epub ahead of print].

Ashton, A. K., Ahrens, K., Gupta, S., and Masand, P. S. Antidepressant-induced sexual dysfunction and Ginkgo Biloba. Am J Psychiatry. 2000;157(5):836-837.

Barrett B, Kiefer D, Rabago D. Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med . 1999;5(4):40-49.

Barth SA, Inselmann G, Engemann R, Heidemann HT. Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation in human liver microsomes in comparison to vitamin E, glutathione and N-Acetylcysteine. Biochem Pharmacol . 1991;41(10):1521-1526.

Benjamin J, Muir T, Briggs K, Pentland B. A case of cerebral haemorrhage-can Ginkgo biloba be implicated? Postgrad Med J . 2001;77(904):112-113.

Birks, J., Grimley, E. V., and Van Dongen, M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database.Syst Rev. 2003;(4):CD003120.

Blumenthal M, Busse WR, Goldberg A, et al., ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines . Boston, Mass: Integrative Medicine Communications; 1998.

Bridi, R., Crossetti, F. P., Steffen, V. M., and Henriques, A. T. The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res 2001;15(5):449-451.

Brinker F. Herb Contraindications and Drug Interactions . 2nd ed. Sandy, Ore: Eclectic Medical; 1998:76-77.

Cheuvront, S. N. and Carter, R., III. Ginkgo and memory. JAMA. 2-5-2003;289(5):547-548.

Christen Y. Oxidative stress and Alzheimer's disease. Am J Clin Nutr . 2000;71(suppl):621S-629S.

Cieza, A., Maier, P., and Poppel, E. Effects of Ginkgo biloba on mental functioning in healthy volunteers. Arch Med Res. 2003;34(5):373-381.

Clostre F. Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000. Ann Pharm Fr . 1999;57(Suppl 1):1S8-88.

Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am Fam Physician . 1999;59(5):1239–1244.

Davydov L and Stirling AL. Stevens-Johnson syndrome with Ginkgo biloba. J Herbal Pharmacother. 2001;1(3):65-69.

Diamond BJ, Shiflett SC, Feiwel N, et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil . 2000;81:669-678.

Drew S, Davies E. Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ . 2001;322(7278):73.

Engelsen, J., Nielsen, J. D., and Hansen, K. F. [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr.Laeger. 4-28-2003;165(18):1868-1871.

Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med . 2002;136:42-53.

Ernst E, Pittler MH. Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials. Clin Drug Invest . 1999;17:301-308.

Ernst E, Stevinson C. Ginkgo biloba for tinnitus: a review. Clin Otolaryngol . 1999;24(3):164-167.

Fong, K. C. and Kinnear, P. E. Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion. Postgrad.Med.J . 2003;79(935):531-532.

Galluzzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB. Coma in a patient with Alzheimer's disease taking low dose trazodone and Ginkgo biloba. J Neurol Neurosurg Psychiatry . 2000;68:679-683.

Hartley, D. E., Elsabagh, S., and File, S. E. Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in post-menopausal women. Nutr Neurosci . 2004;7(5-6):325-333.

Hilton, M. and Stuart, E. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev . 2004;(2):CD003852.

Horsch, S. and Walther, C. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies. Int.J Clin Pharmacol Ther . 2004;42(2):63-72.

Huang, S. Y., Jeng, C., Kao, S. C., Yu, J. J., and Liu, D. Z. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin.Nutr . 2004;23(4):615-621.

Johnson SK, Diamond BJ, Rausch S, Kaufman M, Shiflett SC, Graves L. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial. Explore (NY). 2006;2(1):19-24.

Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Alt Med Rev . 1999;4(3):144-161.

Kampman, K., Majewska, M. D., Tourian, K., et al., A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence. Addict Behav. 2003;28(3):437-448.

Kenney C, Norman M, Jacobson M, and et al. A double-blind, placebo-controlled, modified crossover pilot study of the effects of Ginkgo biloba on cognitive and functional abilities in multiple sclerosis. American Academy of Neurology 54th Annual Meeting . April 13-20 2002;P06.081.

Kim YS, Pyo MK, Park KM, et al. Antiplatelet and antithrombotic effects of a combination of ticlopidine and Ginkgo biloba ext (EGb 761). Thromb Res . 1998;91:33-38.

Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. [Review]. Br J Clin Pharmacol . 1992;34(4):352-358.

Kohler, S., Funk, P., and Kieser, M. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coagul.Fibrinolysis . 2004;15(4):303-309.

LaValle JB, Krinsky DL, Hawkins EB, et al. Natural Therapeutics Pocket Guide . Hudson, OH: LexiComp; 2000:441-442.

Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA . 1997;278:1327–1332.

Le Bars PL, Kieser M, Itil KZ. A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb761 in dementia. Dement Geriatr Cogn Disord . 2000;11:230-237.

Manocha A, Pillai KK, Husain SZ. Influence of Ginkgo biloba on the effect of anticonvulsants. Indian J Pharmacol . 1996;28:84-87.

Mantle D, Pickering AT, Perry AK. Medicinal plant extracts for the treatment of dementia: a review of their pharmacology, efficacy and tolerability. CNS Drugs . 2000;13:201-213.

Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovascular disease. Arch Intern Med . 1998;158(9):2225–2234.

Matthews MK. Association of Ginkgo biloba with intracerebral hemorrhage [letter]. Neurol . 1998;50(6):1933-1934.

Mauro, V. F., Mauro, L. S., Kleshinski, J. F., Khuder, S. A., Wang, Y., and Erhardt, P. W. Impact of ginkgo biloba on the pharmacokinetics of digoxin. Am.J Ther 2003;10(4):247-251.

Mazza M, Capuano A, Bria P, Mazza S. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Eur J Neurol . 2006;13(9):981-5.

Meisel, C., Johne, A., and Roots, I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis. 2003;167(2):367.

Miller LC. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med . 1998;158(9):2200–2211.

Mix JA, Crews WD. An examination of the efficacy of Ginkgo biloba extract Egb 761 on the neuropsychiatric functioning of cognitively intact older adults. J Alt Comp Med . 000;6(3):219-229.

Moher D, Pham B, Ausejo M, Saenz A, Hood S, Barber GG. Pharmacological management of intermittent claudication: a meta-analysis of randomised trials. Drugs . 2000;59(5):1057-1070.

Nathan, P. J., Harrison, B. J., and Bartholomeusz, C. Ginkgo and memory. JAMA . 2-5-2003;289(5):546-548.

Oh SM, Chung KH. Antiestrogenic activities of Ginkgo biloba extracts. J Steroid Biochem Mol Biol . 2006;100(4-5):167-76.

Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol . 1998;55:1409-1415.

Persson, J., Bringlov, E., Nilsson, L. G., and Nyberg, L. The memory-enhancing effects of Ginseng and Ginkgo biloba in healthy volunteers. Psychopharmacology (Berl) 2004;172(4):430-434.

Peters H, Kieser M, Holscher U. Demonstration of the efficacy of Ginkgo biloba special extract Egb 761 on intermittent claudication a placebo-controlled, double-blind trial. Vasa . 1998;27:105–110.

Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med . 2000;108(4):276-281.

Rai GS, Shovlin C, Wesnes KA. A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin 1991;12(6):350-355.

Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med . 1997;336:1108.

Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic ginkgo. Neurol . 1996;46:1775–1776.

Schneider LS, DeKosky ST, Farlow MR, Tariot PN, Hoerr R, Kieser M. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res . 2005;2(5):541-51.

Sikora R, Sohn M, Deutz F-J, et al. Ginkgo biloba extract in the therapy of erectile dysfunction. J Urol . 1989;141:188A.

Trick, L., Boyle, J., and Hindmarch, I. The effects of Ginkgo biloba extract (LI 1370) supplementation and discontinuation on activities of daily living and mood in free living older volunteers. Phytother Res . 2004;18(7):531-537.

Van Dongen, M., van Rossum, E., Kessels, A., Sielhorst, H., and Knipschild, P. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol . 2003;56(4):367-376.

Vellas, B., and Grandjean, H. Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. J Gerontol A Biol.Sci.Med Sci . 2003;58(4):372-377.